[Peripheral thrombopenic purpura associated with acquired toxoplasmosis].
Acquired Toxoplasma Gondii infection has a benign course in adults and children immunologically competent. Thrombocytopenia is much more common during congenital toxoplasma infection and the rare cases of purpura associated with acquired toxoplasmosis are usually not thrombocytopenic. We report a case of thrombocytopenic purpura in an immunocompetent child, associated with active acquired toxoplasmosis. In rare circumstances, acquired toxoplasmosis in an immunocompetent patient may be associated with severe thrombocytopenia. However, the low incidence of such cases makes a therapeutic consensus difficult.
Service de Pédiatrie, C.I.U. Ambroise Paré, Mons.
D
D
Michez
C
C
Quintart
E
E
Noël
P
P
Lepage
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D003049:Coccidiostats / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D017713:Platelet Transfusion; D011239:Prednisolone / Q000627:therapeutic use; D011696:Purpura, Thrombocytopenic / Q000469:parasitology*; D011739:Pyrimethamine / Q000627:therapeutic use; D015572:Spiramycin / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000150:complications*
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D003049:Coccidiostats; D016756:Immunoglobulins, Intravenous; D013411:Sulfadiazine; D015572:Spiramycin; D011239:Prednisolone; D011739:Pyrimethamine